Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FT.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.1.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAGEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.9.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BN.1.4.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DJ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.26.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
FK.1.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HD.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
XBB.1.37.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.77EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FD.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.51EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.52EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.65EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.75EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.18.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GL.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.78EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used